Prussian blue nanozymes were fabricated for atherosclerosis nanotherapy, which could reduce cellular reactive oxygen species level and exert cytoprotective effects against macrophages apoptosis, significantly boycotting atherosclerosis development.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: